Bolivia vs Mozambique: Immunization, measles (% of children ages 12-23 months)
Bolivia
67.0%
in 2024
Mozambique
65.0%
in 2024
Bolivia rank
173rd
Mozambique rank
176th
Immunization, measles (% of children ages 12-23 months) over time
- Bolivia
- Mozambique
How they compare
Bolivia currently reports 67.0% against 65.0% in Mozambique, a difference of 2.0%.
The two have swapped places 11 times across 44 shared years of data; in 1981 it was Mozambique ahead.
Bolivia ranks 173rd and Mozambique ranks 176th of 193 countries.
Across the 5 decades both report, Bolivia averaged higher in 3 and Mozambique in 2.
Head to head by decade
| Decade | Bolivia | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 35.0% | 44.2% | 9.2% | Mozambique |
| 1990s | 59.9% | 61.8% | 1.9% | Mozambique |
| 2000s | 89.7% | 76.7% | 13.0% | Bolivia |
| 2010s | 89.2% | 82.8% | 6.4% | Bolivia |
| 2020s | 70.6% | 65.6% | 5.0% | Bolivia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, Bolivia or Mozambique?
- Bolivia, at 67.0% against 65.0% in Mozambique as of 2024.
- What is the difference in immunization, measles between Bolivia and Mozambique?
- 2.0%, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and Mozambique?
- 44 years are reported by both, from 1981 to 2024.
- How do Bolivia and Mozambique rank globally for immunization, measles?
- Bolivia ranks 173rd and Mozambique ranks 176th of 193 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.